Cato BioVentures is the venture capital affiliate of?Cato Holding, a privately held family fund. For more than 30 years, Cato BioVentures has partnered with entrepreneurs, academic institutions, and a broad base of biotech and pharmaceutical companies to advance a robust portfolio of successful product development programs. Cato BioVentures has invested in innovative therapeutics, medical devices and stem cell technologies that improve Pharma's Research and Development productivity.?We invest in opportunities at all stages of development and across multiple therapeutic areas in both private and public companies. Our goal at Cato BioVentures is to partner with our portfolio companies to make a difference in the successful outcome of your core development programs.